One hundred and sixty patients with head and neck carcinomas were followed from one to 15 years to assess the associations between tobacco usage and the development of multiple head and neck cancers. Seventy-three percent had tobacco habits, with nine of ten users smoking cigarettes. In almost one in five patients (18.1%), second primary oral/oropharyngeal cancers developed in a mean time of five years. Those who did not change their original tobacco habits incurred the greatest risk, as a second primary cancer developed in 30%. Reducing or discontinuing smoking appeared to have a beneficial effect. There was also an increased risk for multiple cancers in males, probably because of their larger amount of daily smoking.

This article has been cited by other articles:

				J. B. Epstein, M. Gorsky, R. J. Cabay, T. Day, and W. Gonsalves Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: Role of primary care physicians Can Fam Physician, June 1, 2008; 54(6): 870 - 875. [Abstract] [Full Text] [PDF]

				F. R. Khuri, J. J. Lee, S. M. Lippman, E. S. Kim, J. S. Cooper, S. E. Benner, R. Winn, T. F. Pajak, B. Williams, G. Shenouda, et al. Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients. J Natl Cancer Inst, April 5, 2006; 98(7): 441 - 450. [Abstract] [Full Text] [PDF]

				R. A. Schnoll, B. Zhang, M. Rue, J. E. Krook, W. T. Spears, A. C. Marcus, and P. F. Engstrom Brief Physician-Initiated Quit-Smoking Strategies for Clinical Oncology Settings: A Trial Coordinated by the Eastern Cooperative Oncology Group J. Clin. Oncol., January 15, 2003; 21(2): 355 - 365. [Abstract] [Full Text] [PDF]

				A. G. Banerjee, V. K. Gopalakrishnan, I. Bhattacharya, and J. K. Vishwanatha Deregulated Cyclooxygenase-2 Expression in Oral Premalignant Tissues Mol. Cancer Ther., December 1, 2002; 1(14): 1265 - 1271. [Abstract] [Full Text] [PDF]

				F. R. Khuri, E. S. Kim, J. J. Lee, R. J. Winn, S. E. Benner, S. M. Lippman, K. K. Fu, J. S. Cooper, E. E. Vokes, R. M. Chamberlain, et al. The Impact of Smoking Status, Disease Stage, and Index Tumor Site on Second Primary Tumor Incidence and Tumor Recurrence in the Head and Neck Retinoid Chemoprevention Trial Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 823 - 829. [Abstract] [Full Text] [PDF]

				J. Cloos, C. R. Leemans, M. L. T. van der Sterre, D. J. Kuik, G. B. Snow, and B. J. M. Braakhuis Mutagen Sensitivity as a Biomarker for Second Primary Tumors after Head and Neck Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 713 - 717. [Abstract] [Full Text]